Try it now — load your own PDF or use the sample: ...
Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...
Abstract: Sixth-generation (6G) mobile communication networks are expected to have dense infrastructures, large antenna size, wide bandwidth, cost-effective hardware, diversified positioning methods, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback